Growth Metrics

Femasys (FEMY) EBITDA Margin (2020 - 2025)

Femasys posted quarterly EBITDA Margin of 941.09% for Q2 2025, up 108260.0% year-on-year from N/an in Q2 2024, and up 41.19% on a QoQ basis from 1600.11% in Q1 2025.

Femasys (FEMY) has 6 years of EBITDA Margin data on file, last reported at 941.09% in Q2 2025.

  • For the quarter ending Q2 2025, EBITDA Margin rose 108260.0% year-over-year to 941.09%; the trailing twelve-month figure through Jun 2025 stood at 1015.0% (up 71910.0% YoY), and the FY2025 full-year result was 766.95%, up 32480.0% from the prior year.
  • EBITDA Margin for Q2 2025 stood at 941.09%, up from 1600.11% in the prior quarter.
  • Across five years, EBITDA Margin topped out at 332.22% in Q2 2021 and bottomed at 2087.89% in Q4 2023.
  • The 5-year median for EBITDA Margin is 926.12% (2021), against an average of 1104.14%.
  • Peak annual rise in EBITDA Margin reached 127586 bps in 2024, while the deepest fall reached 110767 bps in 2024.
  • A 5-year view of EBITDA Margin shows it stood at 929.85% in 2021, then slumped by 38 bps to 1280.87% in 2022, then tumbled by 63 bps to 2087.89% in 2023, then soared by 61 bps to 812.03% in 2024, then slipped by 16 bps to 941.09% in 2025.
  • The last three EBITDA Margin figures came in at 941.09% (Q2 2025), 1600.11% (Q1 2025), and 812.03% (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn 28.86%
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn 1.97%
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn 34.92%
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn 20.96%
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn 4.04%
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn 19.85%
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn 13.65%
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn 2.44%
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn 17.48%
10 Femasys 22.30 Mn 16.91 Mn - -

Historic Data

Download Data 🔒
DateValue
Jun 30, 2025 -941.09%
Mar 31, 2025 -1,600.11%
Dec 31, 2024 -812.03%
Sep 30, 2024 -922.39%
Jun 30, 2024 -2,023.69%
Mar 31, 2024 -1,277.07%
Dec 31, 2023 -2,087.89%
Sep 30, 2023 -1,670.18%
Jun 30, 2023 -916.02%
Mar 31, 2023 -1,034.64%
Dec 31, 2022 -1,280.87%
Sep 30, 2022 -879.88%
Jun 30, 2022 -877.55%
Mar 31, 2022 -896.92%
Dec 31, 2021 -929.85%
Sep 30, 2021 -838.23%
Jun 30, 2021 -332.22%
Mar 31, 2021 -553.88%
Dec 31, 2020 -590.65%
Sep 30, 2020 -500.72%
Jun 30, 2020 -810.69%